Marketing of Pharmaceuticals in Rural India Author(s): V. R. Navelkar and M. D. Banker Source: Economic and Political Weekly, Vol. 13, No. 34 (Aug. 26, 1978), pp. M95-M99 Published by: Economic and Political Weekly Stable URL: http://www.jstor.org/stable/4366894 . Accessed: 02/12/2014 02:27 Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at . http://www.jstor.org/page/info/about/policies/terms.jsp . JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information …show more content…
Indeed, a drug is not so much a product as it is a tool in the healing process very mnuch like the doctor, the midwife, the hospital, the dispensary, etc. Unlike other products of day-to-day use, drugs are never wanted (2) Abotut lhalf of all recorded deaths are among children under five chiefly fronminfectious diseases anid malnutrition. they are needled be- cause they become essential in the treatment of diseases. Therefore, Unlike other expendittures, that on medicines should be looked upon as a cost of keeping onie hale and hearty. The real measure of the value of drugs and the inedutstrywhich produices them. is the therapeuitic jolb which they perforIm. Tlius, the prime responsibility of the lpharimiaccutical indtustry is to search foi, develop and prodtuce better anld newer drugs anlclto uiae them available, thereby assistinig the miledical an(i para-medical p)ersomlmlin their task of tackling the health problems of the people. lHURALT. iIAliT1 AND IROi 01()F PSI)AIIMACEUVICAI., INDUSTIItY A lot has been talkked1 about and written oni this subject in general, and the inadeqttacies of healtlh facilities in particular couniitries. - to the economiiically weaker section of the rurial population. On the government 's side a lot of money and effort has been spent to imiiprove health facilities in the country, more particsularlyin rutral areas, as can be seen from Table 1. The cturrent government thinking highlights the need for
This article was quite different from the previous articles I have read in the class as it poses methods for physicians to analyze treatment benefits. Similar to what we learned in class, the article discusses different types of economic analysis as well as the different types of costs associated with treatments. Although I think that considering economic analysis is a great way for physicians to provide the most beneficial treatment, I
You need to utilize at least two scholarly sources (excluding your text) for this paper and your paper must be formatted according to APA style guidelines as outlined in the Ashford Writing Center.
Your paper must be formatted according to APA style as outlined in the Ashford Writing Center, and it must include citations and references for the text and at least two scholarly sources from the Ashford University Library.
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at . http://www.jstor.org/page/info/about/policies/terms.jsp JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of
Over the years, there has been an immersive increasement in the cost of medication. These high prices have created disputes between individuals, who wish for more affordable medicine and those who believe that the prices are necessary. The cost of medication may be excessively high, but it is important for a variety of reason. The prices of the medication are set in order to fund for research and development, so that researchers can produce more efficient and safer drugs for patients. Although it may be excessive, it may be necessary in order to continue the fundings.
The manufacturers of Sovaldi drug are also of the opinion that government and public officials do not take into account all the benefits mostly economically which emanate from the prescription of the drug. They argue that the high price is very effective in limiting or completely getting done with other hospital expenses that would be incurred in the long run because the drug is effective in the curing of the disease rather than the management of symptoms over the years and, therefore, savings (Charles, 2015). . Most states that try to limit the use of Sovaldi have received lots of lawsuits that analysts say not the definite solution of the underlying problem with Sovaldi being just the first of many highly effective but expensive drugs that are expected in the market due to the ever increasing cases of chronic diseases.
cording to Batnitzky, Hayes and Vinall (2014), fee – for – service (FFS) “is the oldest form of reimbursement method, and in this system, healthcare professionals are paid for every service and test they provide” (p. 3.2). While the opposition would argue this form of reimbursement is the catalyst for medical professionals to “pad their wallets” for profits, FFS is would be equivalent to a professional in another field of work to be compensated for the services they render. FFS has remained within the medical pay system because, medical professionals should not be limited in using all resources at their disposal to ensure the correct diagnosis is achieved as, you cannot take a one size fits all approach when providing care to patients. Treatment
The Johns Hopkins University Press, n.d. Web. 14 Apr.
The increasing expenses of physician prescribed drugs influence the patients who get them and the
Improved drugs can result in improved treatment; however drugs are expensive and there are concerns about over-medication and the influence of drug companies upon the healthcare system
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of
Scholarly Expectations: This paper should include a minimum of five scholarly resources. Do not use your course textbooks or sources from the internet. Be sure to incorporate your sources clearly into your analysis. Drawing upon your sources, your paper should address the content/question below.
Cost-benefit, cost-effectiveness and cost-utility analyses are forms of economic evaluation which are useful in health economics for comparing costs and allocating resources. Health economics is widely relevant to governments and the health sector in implementation of new policy, as it concerns the allocation of resources in the context of a limited budget, or 'scarcity'. Economic evaluation is a potential tool for setting priorities in health, though it is only one of many potential criteria, including overall budget and public attitudes and wants. Economic evaluation is already in use in some settings, such as in pharmaceutical company proposals for government subsidisation, but there is room for expansion across the field of
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For